Eosinophil Recruitment Following Allergen Challenge Is Associated with the Release of the Chemokine RANTES into Asthmatic Airways

Journal of Immunology

Volumn 157, Issue 4, 1996, Pages 1806-1812

  Teran, Luis M ^a,b,c   Noso, Norio ^b   Carroll, Mary ^a   Davies, Donna E ^a   Holgate, Stephen ^a   Schröder, Jens M ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF KIEL   (Germany)

^c Department of Dermatology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EOSINOPHIL CHEMOTACTIC FACTOR; RANTES;

ADULT; ARTICLE; ASTHMA; CHEMISTRY; CYTOLOGY; EOSINOPHIL; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOLOGY; INHALATION TEST; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION;

ADULT; ALLERGENS; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOTACTIC FACTORS, EOSINOPHIL; EOSINOPHILIA; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE COUNT; MALE; RANTES;

EID: 0030586684     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Wardlaw, A. J., S. Dunnette, G. J. Gleich, J. V. Collins, and A. B. Kay. 1988. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62.
2. Djukanović, R., J. W. Wilson, K. M. Britten, S. J. Wilson, A. F. Walls, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1990. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am. Rev. Respir. Dis. 142: 863.
3. Liu, M. C., W. C. Hubbard, D. Proud, B. A. Stealey, S. J. Galli, A. Kagey-Sobotka, E. R. Bleecker, and L. M. Lichtenstein. 1991. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular mediator, and permeability changes. Am. Rev. Respir. Dis. 144:51.
4. Metzger, W. J., H. B. Richerson, K. Worden, M. Monick, and G. W. Hunninghake. 1986. Bronchoalveolar lavage of allergic asthmatic patients following allergen provocation. Chest 89:477.
5. Gleich, G. J., E. Frigas, D. A. Loegering, D. L. Wassom, and D. Steinmuller. 1979. Cytotoxic properties of the eosinophil major basic protein. J. Immunol. 123:2925.
6. 4. Proc. Natl. Acad. Sci. USA 80:7626.
7. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, A. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. Michael. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033.
8. Miller, M. D., and M. S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17.
9. Kameyoshi, Y., A. Dorschner, A. I. Mallet, E. Christophers, and J. Schröder. 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176:587.
10. Noso, N., P. Proost, J. van Damme, and J. Schröder. 1994. Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem. Biophys. Res. Commun. 200:1470.
11. Metzger, W. J., D. Zavala, H. B. Richerson, P. Moseley, P. Iwamota, M. Monick, K. Sjoedrdsma, and G. W. Hunninghake. 1987. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: description of the model and local airway inflammation. Am. Rev. Respir. Dis. 135:433.
12. Montefort, S., C. Gratziou, D. Goulding, R. Polosa, D. O. Haskard, P. H. Howarth, and S. T. Holgate. 1994. Bronchial biopsy evidence for leukocyte infiltration of leukocyte-endothelial cell adhesion molecules 6 h after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest. 93:1411.
13. Chai, H., R. S. Farr, L. A. Froehlich, D. A. Mathison, J. A. McLean, R. A. Rosenthal, A. L. Sheffer II, S. L. Spector, and R. G. Townley. 1975. Standardization of bronchial inhalation challenge procedures. J. Allergy Clin. Immunol. 56:323.
14. National Heart, Lung, and Blood Institute. 1992. Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J. Allergy Clin. Immunol. 88:808.
15. Krug, N., L. M. Teran, A. E. Redington, C. Gratziou, S. Montefort, R. Polosa, H. Brewster, P. H. Howarth, S. T Holgate, A. J. Frew, and M. P. Carroll. 1996. Safety aspects of local endobronchial allergen challenge in asthmatic patients. Am. J. Respir. Crit. Care Med. 153:1391.
16. Schröder, J., and E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks interleukin-1 activity. J. Immunol. 139:3474.
17. Sticherling, M., M. Kupper, F. Koltrowitz, E. Bornscheuer, R. Kulke, M. Klinger, D. Wilhelm, Y. Kameyoshi, E. Christophers, and J. Schröder. 1995. Detection of chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J. Invest. Dermatol. 105:585.
18. Weeke, B. 1973. Rocket immuno-electrophoresis. Scand. J. Immunol. 2:37.
19. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model. J. Exp. Med. 183:195.
20. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109.
21. Broide, D. H., and G. S. Firestein. 1991. Endobronchial allergen challenge in asthma: demonstration of cellular source of granulocyte colony-stimulating factor by in situ hybridization. J. Clin. Invest. 88:1048.
22. Beasley, C. R. W., W. R. Roche, J. A. Roberts, and S. T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:806.
23. Spencer, D. P. S., S. L. Johnston, P. M. A. Calverley, P. Dhillon, C. Higgins, E. Ramhamadany, S. Turner, A. Winning, J. Winter, and S. T. Holgate. 1994. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am. J. Respir. Crit. Care Med. 149:1142.
24. Schwenk, U., and J. Schröder. 1995. 5-Oxo-eicosanoids are potent eosinophil chemotactic factors. J. Biol. Chem. 270:15029.
25. Cruikshank, W. W., A. Long, R. E. Tarpy, H. Kornfeld, M. P. Carroll, L. M. Teran, S. T. Holgate, and D. M. Center. 1995. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein-1α (MIP-1α) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am. J. Respir. Cell Mol. Biol. 13:738.
26. Rot, A., M. Krieger, T. Brunner, S. C. Bischoff, T. J. Schall, and C. A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1489.
27. Wang, J. M., A. Rambaldi, A. Biondi, Z. G. Chen, C. J. Sanderson, and A. Mantovani. 1995. Recombinant human interleukin-5 is a selective eosmophil chemoattractant. Eur. J. Immunol. 19:701.
28. Alam, R., S. Stafford, P. Forsythe, R. Harrison, D. Faubion, M. A. Lett Brown, and J. A. Grant. 1993. RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 150:3442.
29. Ebisawa, M., T. Yamada, C. Bickel, D. Klunk, and R. P. Schleimer. 1994. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J. Immunol. 153:2153.
30. Humbert, M., S. Ying, J. Barkans, B. Assoufi, Q. Meng, S. Durham, and A. B. Kay. 1995. Elevated gene expression of RANTES and monocyte chemotactic protein-3 (MCP-3) in bronchial biopsies from asthmatics. Am. J. Respir. Crit. Care Med. 151:618.
31. Ponath, P. D., S. Qin, D. J. Ringier, I. Clarck-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J. Gonzalo, W. Newman, J. Gutierrez-Ramos, and C. R. MacKay. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. J. Clin. Invest. 97:604.
32. Garcia-Zepeda, E. A., M. E. Rothenherg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is an eosinophil selective chemoattractant that provides a new mechanism to explain tissue eosinophilia. Nature Medicine 2:449.
33. Warringa, R. A., H. J. Mengelers, J. A. Raijmakers, P. L. Bruijnzeel, and L. Koenderman. 1993. Up-regulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J. Allertgy Clin. Immunol. 91:1198.
34. Sehmi, R., O. Cromwell, A. J. Wardlaw, R. Moqbel, and A. B. Kay. 1994. Interleukin-8 is a chemoattractant for eosinophils purified from subjects with a blood eosinophilia but not normal healthy subjects. Clin. Exp. Allergy 23:1027.
35. Schröder, J., N. Noso, M. Sticherling, and E. Christophers. 1996. Role of eosinophil-chemotactic CC chemokines in cutaneous inflammation. J. Leukocyte Biol. 59:1.
36. Meurer, R., G. Van Riper, W. Feeney, P. Cunningham, D. Hora, Jr., M. S. Springer, D. E. MacIntyre, and H. Rosen. 1993. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. J. Exp. Med. 178: 1913.
37. Alam, R., J. York, M. Boyars, S. Stafford, J. A. Grant, J. Lee, P. Forsythe, T. Sim, and N. Ida. 1996. Increased MCP-1, RANTES and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 153: 1398.
38. Sim, T. C., L. M. Reece, K. A. Hilsmeier, J. A. Grant, and R. Alam. 1995. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am. J. Respir. Crit. Care Med. 152:927.
39. Ying, S., L. Taborda-Barata, Q. Meng, M. Humbert, and A. B. Kay. 1995. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J. Exp. Med. 181:2153.
40. Wang, J. H., J. L. Devalia, C. L. Xia, R. J. Sapsford, and R. J. Davies. 1996. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am. J. Respir. Cell Mol. Biol. 14:27.
41. Schall, T. J., J. Jongstra, B. J. Dyer, J. Jorgensen, C. Clayberger, M. M. Davies, and A. M. Krensky. 1988. A human T-cell specific molecule is a member of a new gene family. J. Immunol. 141:1018.
42. Devergne, O., A. Marfaing Koka, T. J. Schall, M. B. Leger Ravet, M. Sadick, M. Peuchmaur, M. C. Crevon, K. J. Kim, and et al. 1994. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells [published erratum appears in J Exp Med 1994 Aug 1;180(2):775]. J. Exp. Med. 179:1689.
43. Rathanaswami, P., M. Hachicha, M. Sadick, T. J. Schall, and S. R. McColl. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts: differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J. Biol. Chem. 268:5834.
44. Hastie, A. T., D. A. Loegering, and G. J. Gleich. 1987. The effect of purified human eosinophil major cationic protein on mammalian ciliary activity. Am. Rev. Respir. Dis. 135:685.
45. Flavahan, N. A., N. R. Slifman, G. J. Gleich, and P. M. Vanhoutte. 1988. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: role of the epithelium. Am. Rev. Respir. Dis. 138:685.